DZNE scientists have discovered a molecular mechanism that may help in the search for effective treatments of progressive supranuclear palsy (PSP). Their study focusses on a protein called PERK.
Today, Federal Chancellor Angela Merkel and NRW Science Minister Svenja Schulze inaugurated the new building of the DZNE in Bonn and took the opportunity to learn about current research projects.
Scientists from BfArM and the DZNE will be working together and in cooperation with the statutory health insurance company Techniker Krankenkasse to investigate the influence of pharmacogenetic factors on the effectiveness and safety of drug therapies.
In a laboratory study, DZNE researchers have found that "alpha-synuclein", a protein involved in Parkinson's disease, is capable of travelling from the brain to the stomach using the vagus nerve as a conduit.
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
